1. “Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy”
by Sinha, D.; Roy, S.; Saha, P.; Chatterjee, N.; Bishayee, A.
Cancers 2021, 13(2), 326; https://doi.org/10.3390/cancers13020326
Available online: https://www.mdpi.com/2072-6694/13/2/326
2. “Mechanisms of Resistance to KRASG12C Inhibitors”
by Dunnett-Kane, V.; Nicola, P.; Blackhall, F.; Lindsay, C.
Cancers 2021, 13(1), 151; https://doi.org/10.3390/cancers13010151
Available online: https://www.mdpi.com/2072-6694/13/1/151
3. “Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter”
by Hompland, T.; Fjeldbo, C. S.; Lyng, H.
Cancers 2021, 13(3), 499; https://doi.org/10.3390/cancers13030499
Available online: https://www.mdpi.com/2072-6694/13/3/499
4. “Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression”
by Papatsirou, M.; Artemaki, P. I.; Karousi, P.; Scorilas, A.; Kontos, C. K.
Cancers 2021, 13(11), 2744; https://doi.org/10.3390/cancers13112744
Available online: https://www.mdpi.com/2072-6694/13/11/2744
5. “Targeting CDK9 for Anti-Cancer Therapeutics”
by Mandal, R.; Becker, S.; Strebhardt, K.
Cancers 2021, 13(9), 2181; https://doi.org/10.3390/cancers13092181
Available online: https://www.mdpi.com/2072-6694/13/9/2181
6. “EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance”
by Uribe, M. L.; Marrocco, I.; Yarden, Y.
Cancers 2021, 13(11), 2748; https://doi.org/10.3390/cancers13112748
Available online: https://www.mdpi.com/2072-6694/13/11/2748
7. “The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma”
by Ou A.; Ott M.; Fang D.; Heimberger A. B.
Cancers 2021, 13(3), 437; https://doi.org/10.3390/cancers13030437
Available online: https://www.mdpi.com/2072-6694/13/3/437
8. “Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer”
by Domen, A.; Quatannens, D.; Zanivan, S.; Deben, C.; Van Audenaerde, J.; Smits, E.; Wouters, A.; Lardon, F.; Roeyen, G.; Verhoeven, Y.; Janssens, A.; Vandamme, T.; van Dam, P.; Peeters, M.; Prenen, H.
Cancers 2021, 13(5), 987; https://doi.org/10.3390/cancers13050987
Available online: https://www.mdpi.com/2072-6694/13/5/987
9. “Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies”
by Hattinger, C. M.; Patrizio, M. P.; Fantoni, L.; Casotti, C.; Riganti, C.; Serra, M.
Cancers 2021, 13(12), 2878; https://doi.org/10.3390/cancers13122878
Available online: https://www.mdpi.com/2072-6694/13/12/2878
10. “Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing”
by Kabakov, A. E.; Yakimova, A. O.
Cancers 2021, 13(5), 1102; https://doi.org/10.3390/cancers13051102
Available online: https://www.mdpi.com/2072-6694/13/5/1102
